InsidersTradesSigma
Explore the detailed record of transactions filed by Marsh Linda, Director. Director active across 2 companies, notably Fulgent Genetics, Inc.. In total, 4 reports have been logged. Total volume traded: €8.8m. The latest transaction was disclosed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Linda Marsh is a Board Member at Fulgent Genetics, Inc. and Apollo Medical Holdings, Inc. She brings expertise in management and strategy, contributing to decision-making within the boards. Her role includes overseeing operations and developing policies to ensure compliance and ethics within the organizations.